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Due to the baby boom after World War II and an (still) increasing life expectancy, 
around 25% of the Dutch population is 65 years of older, of which more than 30% is 
older than 80 years in 2050 (www.cbs.nl). One of the most challenging aspects of an 
ageing population is to preserve or improve a good physical and mental health of 
older adults (WHO, 2015). From a medical perspective, interventions should be 
focused on those people with the highest risk of adverse health outcomes (Fried et 
al., 2001; Collard et al., 2012; WHO, 2015). To this end, frailty has been introduced 
as a core concept in geriatric medicine as frail older persons have the highest risks 
of adverse health outcomes and are high users of community resources, 
hospitalization, and nursing homes (Morley et al., 2013). While the relevance of 
frailty is increasingly recognized in geriatric as well as general medicine, this concept 
is largely ignored in geriatric psychiatry. This is remarkable, as several psychiatric 
disorders, in particular depression, negatively interfere with life-expectancy 
(Cuijpers et al., 2014; Brandao et al., 2019). This thesis focusses on the validity and 
clinical relevance of frailty in late-life depression.  
 
Depression - a disorder of accelerated aging  
Globally, depression contributes significantly to the burden of disease (Lépine & 
Briley, 2011) and is identified as an independent predictor for the onset of many 
chronic somatic diseases (Penninx et al., 2013). Current predictions indicate that by 
2020, depression will be the second leading cause of disease burden, and by 2030 it 
probably will be the leading cause worldwide (www.who.int). In later life, depression 
has higher recurrence rates, a more chronic course, and a higher level of co-
morbidity with cognitive impairment and somatic diseases (Comijs et al., 2011; 
Schaakxs et al., 2018). The prevalence of depressive disorder according to the 
diagnostic criteria of the DSM or ICD classification systems is estimated at 1.8% 
among community-dwelling people aged 55 years and older (Beekman et al, 1999) 
and 7.2% among older adults aged 75 years and over (independent of the living 
12
 
arrangement) (Luppa et al, 2012). Furthermore, in older populations, subthreshold 
depression is more prevalent than a major depressive disorder (Hasin et al., 2005; 
Fiske et al., 2009), with prevalence rates estimated between 13.5% and 17.5% 
(Beekman et al., 1999; Luppa et al., 2012). As these latter estimates are often based 
on self-report symptom scales, confounding by underlying and/or subthreshold 
somatic diseases cannot be excluded (Thombs et al., 2010). Thus far, studies on the 
impact of depression on the onset of somatic diseases have not included physical 
frailty as a confounding and/or mediating variable (Collard et al., 2015). 
 
The hypothesis that depression itself is a clinical condition of accelerated aging 
(Verhoeven et al., 2014) has originated from findings that depression is prospectively 
associated with the onset of chronic somatic diseases and an increased mortality 
rate independent of lifestyle characteristics (Cuijpers et al., 2013; Penninx et al., 
2013). This hypothesis is further fed by associations between ageing-related 
biomarkers and depressive disorder (e.g. Howren et al., 2009; Dowlati et al., 2010; 
Wolkowitz et al., 2011; Pan et al., 2012; Verhoeven et al., 2014; Morrison et al., 
2019). Most studies on the association between ageing biomarkers and depression 
did not take frailty into account. This might be relevant, as frailty and depression 
share partly overlapping diagnostic criteria as well as assumed underlying 
pathophysiological mechanisms (Mezuk et al., 2012), see below for more detailed 
discussion. Therefore, in this thesis, we examined the association between frailty 
and ageing-related biomarkers of ageing among depressed older patients. We 
examined specifically low graded inflammation (chapter 2), shortened telomere 
length (chapter 3), and lowered vitamin D levels (chapter 4).  
 
Low graded inflammation - This process of accelerated aging is thought to occur as 
a result of dysregulations in immune responses that may contribute to changes of 




life depression (Alexopoulos & Morimoto, 2011). The aging process creates a 
condition of chronic low-grade inflammation, also called “inflamm-ageing” 
(Grolleau-Julius et al., 2010) that leads to the production of several pro-
inflammatory cytokines (Alexopoulos & Morimoto, 2011). Many studies focused on 
the association of cytokines and depression, and found that C-reactive protein as 
well as pro-inflammatory cytokine levels were increased in older adults with 
depressive symptoms (Dentino et al., 1999; Penninx et al., 2003; Tiemeier et al., 
2003; Bremmer et al., 2008; Milaneschi et al., 2009; Zalli et al., 2016), albeit negative 
studies have also been reported (Stewart et al., 2009; Matsushima et al., 2015).   
 
Shortened telomere length - Telomere length is widely considered as a marker of 
cellular aging, as shortened telomeres in white blood cells are associated with 
increased mortality rates (Cawthon et al., 2003; Honig et al., 2006) and the onset of 
various age-related diseases (Collado et al., 2007; Willeit et al., 2010). Associations 
between shortened leucocyte telomere length and depression in young- and middle-
aged patients have been found (e.g. Epel et al., 2004; Damjanovic et al., 2007; 
Kananen et al., 2010; Tyrka et al., 2010; Garcia-Rizo et al., 2013; Verhoeven et al., 
2014; Lin et al., 2016). However, these findings could not be replicated in the 
Netherlands Study of Depression in Older persons (NESDO) (see appendix) (Schaakxs 
et al., 2015). This has amongst others been explained by the fact that late-life 
depression has a more heterogeneous nature as compared to depression earlier in 
life, which may mask (small) effects pertaining to specific subgroups. Whether this 
subgroup is characterised by the presence of physical frailty has not been examined 
yet.  
 
Vitamin D deficiency - Vitamin D is involved in various cellular ageing processes, 
including proliferation, cellular differentiation, and apoptosis (Pusceddu et al., 2015; 
Berridge, 2017). In human studies, an inverse association between vitamin D and 
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ageing-related diseases and mortality has been reported (Pusceddu et al., 2015). A 
growing body of evidence relates lower vitamin D levels to physical frailty (Shardell 
et al., 2009; Chang et al., 2010; Wilhelm-Leen et al., 2010; Ensrud et al, 2011; Smit 
et al., 2012; Hirani et al., 2013; Pabst et al., 2015; Ju et al., 2018). Low vitamin D 
levels may to some extent predict frailty and could represent a biomarker for 
identifying older adults at risk for frailty (Buta et al., 2017). Underlying mechanisms 
of this relationship may be the involvement of vitamin D in sarcopenia, which is 
closely related to frailty, as vitamin D stimulates of Ca2+ and phosphorus transport, 
muscle contraction, and muscle differentiation (Garcia et al., 2011; Ju et al., 2018). 
The association between vitamin D deficiency and depression has been widely 
debated (Kerr et al., 2015). While low levels of vitamin D are consistently associated 
with depression (Anglin et al., 2013; Spedding, 2014), meta-analyses of treatment 
studies have reported no significant effects on depression after vitamin D 
supplementation (Li et al., 2013; Shaffer et al., 2014).  
 
Frailty - a concept of biological aging 
Frailty is a vulnerability state characterized by poor resolution of homeostasis after 
a stressor, placing persons at risk of iatrogenic damage, dependency and death 
(Morley et al., 2013). A consensus group, consisting of frailty-experts and delegates 
from six major international societies, defined physical frailty as an important 
medical syndrome with multiple causes and contributors that is characterized by 
diminished strength, endurance, and reduced physiologic function (Morley et al., 
2013). This concept of physical frailty was considered relevant to target geriatric care 
to the most vulnerable patients. Promising prevention and treatment strategies for 
physical frailty included reduction or prevention of polypharmacy, more physical 
exercise, protein-calorie supplementation, and regular monitoring of vitamin D 




persons aged 65 years and over, the mean prevalence rate of physical frailty was 
9.9% (range 4.0 – 17.0%) (Collard et al., 2012).  
 
Two dominant operationalisations are 1) the deficit accumulation model (Frailty 
Index), stating that the proportion of ageing-related deficits reflects biological age 
on top of chronological age, and 2) the Fried Frailty Phenotype, which mark an 
underlying physiological state of multisystem and energy dysregulation (Fried et al., 
2001; Mitnitski et al, 2001; Cesari et al., 2014). According to Cesari et al (2014), the 
Fried Frailty Phenotype and the Frailty Index should not be considered substitutable 
with each other, but as complementary constructs.  
 
The Frailty Index has been developed in the Canadian Study of Health and Aging 
(CSHA), a five-year prospective cohort study which included 10.263 older adults 
aged 65 years and older (Rockwood et al., 2005). The Frailty Index was originally 
calculated by measuring the absence or presence of 92 clinical deficits (Mitnitski et 
al., 2001; Mitnitski et al., 2002; Rockwood et al., 2005). Ongoing research has shown 
that the Frailty Index is not dependent on the number of deficits taken into account, 
as long as at least 30 deficits from several health domains have been included. 
However, the Frailty Index may substantially overlap with psychiatric conditions, as 
several measures of mental and cognitive capacity are included.  
 
The Fried Frailty Phenotype is defined as the presence of at least three out of five 
criteria, i.e. weight loss, exhaustion, weakness, slowness, and reduced physical 
activity. This definition has been validated in the Cardiovascular Health Study (CHS), 
showing predictive value for incident falls, worsening mobility, hospitalization, and 
death during follow-up independent of multimorbidity or disability (Fried et al., 
2001). Although the Fried Frailty Phenotype has been used by many researchers, the 
operationalisation of the specific components slightly differs between studies. Some 
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studies have shown that self-report indices of the five components also provide a 
reliable proxy of the Fried Frailty Phenotype (Lee et al., 2017; Papachristou et al., 
2017). In this thesis, frailty has been defined according to the Fried Frailty Phenotype 
(Fried et al., 2001). We assumed that this model would be most appropriate for 
application in a psychiatric setting in order to prevent symptom overlap and 
confounding with psychiatric disorders. It allows us to study frailty in relation to 
psychiatric disorders without including psychopathology in the broad definition of 
frailty (Fried et al., 2001; Collard et al., 2012). Hereby, we would be able to 
disentangle the relationship between psychopathology, frailty, and underlying 
ageing mechanisms as well as the clinical impact of frailty in geriatric psychiatry 
(Collard et al., 2012). 
 
Frailty and depression - approaching concepts with increasing age? 
Depression is, analogously to frailty, associated with negative health outcomes, 
including somatic diseases and increased mortality rates (Penninx et al, 2013; 
Cuijpers et al, 2014). Nonetheless, in the hallmark study of Fried and colleagues 
(2001) on the Fried Frailty Phenotype, depressed patients or persons on 
antidepressants were a priori excluded to prevent being classified as physically frailty 
due to the presence of only one (psychiatric) disorder (Fried et al, 2001). This might 
unnecessarily have contributed to the neglect of the concept of frailty in geriatric 
psychiatry.  
 
A narrative review on the association between depression and frailty points not only 
to overlap between both conditions, but also to similarities in the determinants and 
consequences of both concepts (Mezuk et al., 2012). The overlap between both 
constructs has been confirmed in empirical studies. Using latent class analyses 
among adults aged 41 – 96 years, depression and physical frailty appeared to be 




as physically frail (Mezuk et al., 2013). Moreover, factor analyses on the criteria for 
depression and frailty in the Health and Retirement Study, showed that depression 
and frailty represent two distinct, but highly associated dimensions (Lohman et al, 
2016). These findings suggest that frailty and depression in later life are difficult to 
disentangle. A recent meta-analysis on the association between depression and 
frailty among older adults estimated that across cross-sectional studies, 40.4% of 
depressed persons were frail and that 38.6% of frail persons were depressed (Soysal 
et al., 2017). A limited number of longitudinal studies confirmed these findings 
(Soysal et al., 2017). Therefore, frailty and late-life depression may partly share some 
of their etiological pathways as well as their phenotypic expression (Ni Mhaolain et 
al., 2012). Nonetheless, only three studies included in the above mentioned meta-
analysis have assessed depression according to the diagnostic criteria of the DSM, 
among which a study from the Netherlands Study of Depression in Older persons 
(NESDO). In NESDO, only 27.2% of the patients suffering from a DSM-IV defined 
depressive disorder were classified physically frail, which could not be explained by 
overlapping criteria for frailty and depression (Collard et al., 2014). These prevalence 
rates are comparable to the prevalence of frailty among populations with chronic 
somatic conditions in which the clinical relevance of frailty becomes more and more 
evident (Denfeld et al., 2017). 
Thus far, frailty has neither been examined as a determinant of the course of 
depression nor of an increased mortality rate in late life depression, as done in 
chapter 7 and chapter 8.  
 
Frailty and common (neuro)psychiatric symptoms in later life   
While studies on the association between psychopathology and frailty primarily 
focusses on depression, frailty is probably as relevant for other (neuro)psychiatric 
disorders (Andrew & Rockwood, 2007). Therefore, in this thesis we also investigate 
the association between physical frailty and neuropsychiatric disorders in later life. 
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We will focus on “cognitive impairment” and “medically unexplained symptoms” 
(MUS).  
 
Cognitive impairment - The association between physical frailty and cognitive 
performance is complex (Malmstrom et al., 2013; Panza et al., 2014). A systematic 
review has identified eleven longitudinal studies that show the predictive value of 
physical frailty for subsequent cognitive decline or dementia (Robertson et al., 
2013). Although less often studied, cognitive impairment conversely may be a risk 
factor of physical frailty (Robertson et al., 2013; Nishiguchi et al., 2015). Some 
researchers have included cognitive deficits as a component of physical frailty for 
two reasons. Firstly, adding cognitive performance to a frailty index adds to its 
predictive validity for adverse health outcomes (Ávila-Funes et al., 2009). Secondly, 
significant overlap exists in the mechanisms underlying physical frailty and cognitive 
impairment (Halil et al., 2015). In 2013, the concept “cognitive frailty” has been 
introduced by a consensus panel to emphasize the important role of brain aging 
(Kelaiditi et al., 2013). Cognitive frailty was defined as a subtype of physical frailty 
and characterized by the concurrence of cognitive deficits in physically frail older 
persons in the absence of an accompanying neurological disorder (Kelaiditi et al., 
2013). Cognitive frailty may represent a prodromal phase for neurodegenerative 
diseases (Kelaiditi et al., 2013), but its potential for reversibility makes it an ultimate 
target for early intervention (Kelaiditi et al., 2013). Late-life depression can also have 
a detrimental effect on cognitive performance (Panza et al., 2009; Wilkins et al., 
2009; Korten et al., 2014; Panza et al., 2014). Nonetheless, the association between 
physical frailty and cognitive performance has been hardly studied among clinically 
depressed older persons (as will be done in chapter 5).  
 
Medically unexplained symptoms - Medically unexplained symptoms (MUS) are 




be explained in terms of a conventionally defined medical disease (Wessely, 1999; 
Beck, 2008). Patients with medically unexplained symptoms (MUS) often describe a 
low quality of life and frequently suffer from co-morbid anxiety and depressive 
disorders (De Waal et al., 2004). This gives rise to high levels of health care 
consumption in the search for an organic origin of complaints and places especially 
older persons at risk for iatrogenesis (Smith et al., 2005). Besides a small pilot study 
(Benraad et al., 2013), no studies have been conducted on the physical performance 
of older patients with MUS. This pilot study suggests that MUS in later life might be 
related to the presence of frailty. Therefore, in this thesis we want to examine the 
association between frailty and somatic comorbidity among older patients with MUS 
and older patients with Medically Explained Symptoms (MES) who have participated 
in the “Older Persons with medically Unexplained Symptoms” (OPUS) study (see 
appendix). We will particularly explore the association between the severity of MUS 




Aims and outlines of this thesis 
The main aim of this thesis is to study physical frailty in an older population of 
depressed older adults. This thesis consists of three parts. 
 
Part I:  
Ageing-related biomarkers of physical frailty in late-life depression. 
The huge variability in biological ageing among individuals who live in a population 
characterised by an increasing life expectancy has stimulated the search for 
biomarkers of biological ageing. Ageing-related biomarkers should be associated 
with physical frailty as a clinical phenotype of ageing, but also with conditions of 
accelerated ageing like depression. This first part of the thesis focuses on the 
relationship between physical frailty and age-related biomarkers in a population of 
depressed older adults. As physical frailty and late-life depression partly overlap and 
the association between depression and ageing-related biomarkers decreases with 
age, we examined whether associations between ageing-related biomarkers and 
physical frailty were moderated by the presence of a late-life depression within the 
Netherlands Study of Depression in Older persons (NESDO). The specific research 
questions that have to be answered are (numbers corresponding with chapters): 
• Chapter 2: Is physical frailty associated with low-grade inflammation in a cohort 
of depressed older patients? 
• Chapter 3: Is physical frailty associated with telomere length in a cohort of 
depressed older patients? 
• Chapter 4: Is physical frailty associated with vitamin D levels in a cohort of 








Part II:  
Association between physical frailty and common (neuro)psychiatric symptoms. 
The operationalisation of the concept of (physical) frailty is still debated and 
psychiatric disorders beyond depression have also been associated with increased 
mortality rates. Therefore, the idea underlying this second part is the question 
whether the physical frailty phenotype should be broadened with neuropsychiatric 
symptoms beyond depression. Firstly, we set up a study to explore whether physical 
frailty is associated with poorer cognitive functioning in a sample of depressed older 
adults. Secondly, we examined the level of physical frailty and somatic comorbidity 
in older patients with medically unexplained symptoms (MUS) and compared this to 
patients with medically explained symptoms (MES). The following research 
questions have to be answered: 
• Chapter 5: Is cognitive impairment in late-life depression associated with 
physical frailty? 
• Chapter 6: Are medically unexplained symptoms in later life associated with 
physical frailty? 
 
Part III:  
Adverse health outcomes of physical frailty in late-life depression. 
The third part of the thesis is more clinically oriented by focusing on the predictive 
value of physical frailty in late-life depression. First, we investigated the prognostic 
impact of frailty on the outcome and course of late-life depression. Secondly, we 
examined whether physical frailty predicts mortality among clinically depressed 
older persons. The corresponding research questions are: 
• Chapter 7: Does physical frailty negatively impacts the course of depression in 
later life?   





Netherlands Study of Depression in Older persons (NESDO) 
The NESDO study was set up to study neurobiological, physical, and psychosocial 
determinants and the course of late-life depression. NESDO is a multisite, naturalistic 
cohort study (Comijs et al., 2011) and included 378 older (>= 60 years) participants 
with a 6-months diagnosis of major or minor depression or dysthymia, as well as a 
comparison group of 132 never depressed participants (>= 60 years). Depressed 
participants were recruited in primary care as well as secondary and tertiary mental 
health care institutes. Non-depressed controls were recruited from general 
practices only. Exclusion criteria were a suspected or established diagnosis of 
dementia or a Mini Mental State Examination-score <18 (Folstein et al., 1975) and 
insufficient command of the Dutch language. Participants were followed-up for six 
years including self-report symptom severity scales every six months by post and full 
re-examinations at two- and six-year follow-up (site visits). A more detailed 
description of the NESDO study can be found elsewhere (Comijs et al., 2011; Comijs 
et al., 2015; Jeuring et al., 2018). 
 
Older Persons with medically Unexplained Symptoms (OPUS) Study 
The OPUS study was set up to explore the biopsychosocial determinants and course 
of medically unexplained symptoms (MUS) in later life. A mixed method design has 
been adopted by including both quantitative and qualitative data collection. In this 
thesis, only the quantitative baseline assessment will used, which consists of a case-
control study of 118 older MUS-patients (>60 years) with chronic MUS (>3 months) 
to 154 older patients with chronic (>3 months) medically explained symptoms (MES), 
such as diabetes or COPD. To compose a sample of patients representing the whole 
severity range of MUS, participants with MUS and MES were recruited in the 
community (advertisements in local newspapers), in primary care, and in secondary 




department of a University Medical Center). Exclusion criteria were the presence of 
a primary psychotic disorder, cognitive impairment, terminal illness, severe auditory 
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